When was Optain founded?

Optain was founded in 2023 and raised its 1st funding round within a year of its incorporation.

Where is Optain located?

Optain is headquartered in New York City, United States.

How many employees does Optain have?

As of Sep 30, 2026, the latest employee count at Optain is 47.

Is Optain a funded company?

Optain is a funded company, having raised a total of $38M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 09, 2023.

When was the latest funding round of Optain?

Optain's latest funding was a $***** Series A round on Mar 20, 2025, with participation from 9 investors.

Where does Optain rank among its competitors?

Optain ranks 5th amongst 48 active competitors, of which 17 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was PeriVision, which secured $3M in Sep, 2025.

Who are the top competitors of Optain?

Optain's top competitors include Remidio, Intelligent Retinal Imaging Systems and PeriVision. Among them, PeriVision secured the most recent funding round in September, 2025.

Optain - 2026 Company Profile, Funding & Competitors

Optain is a series A company based in New York City (United States), founded in 2023. It operates as an AI-powered retinal imaging technology for non-invasive evaluation of patients. Optain has raised $38M in funding from Insight Partners. The company has 48 active competitors, including 17 funded and 1 that has exited. Its top competitors include companies like Remidio, Intelligent Retinal Imaging Systems and PeriVision.

Company Details

AI-powered retinal imaging technology for non-invasive evaluation of patients. The company uses AI-enabled algorithms and retinal imaging to develop portable, cloud-connected, automated fundus cameras to democratize access to retinal imaging.

Key Metrics

Founded Year

2023

Location

New York City, United States

Stage

Series A

Total Funding

$38M in 2 rounds

Latest Funding Round

Series A, Mar 20, 2025, $*****

Investors

Insight Partners & 9 more

Ranked

5^th among 48 active competitors

Employee Count

47 as on Sep 30, 2026

Investment & Acquisitions

EyePACS

Similar Companies

Remidio & 51 more

View Optain's full profile

Optain is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Optain Health, Inc. CIN: 921517435 , United States, Active	Jul 30, 2023	-	-	-

Optain has raised a total funding of $38M over 2 rounds. Its first funding round was on May 09, 2023. Its latest funding round was a Series A round on Mar 20, 2025 for $*****. 9 investors participated in its latest round. Optain has 10 institutional investors.

Here is the list of recent funding rounds of Optain:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2025	1187893	Series A	3452562	2997876	1227615	7255280
May 09, 2023	3058458	Seed	4605164	6034043	7513238	9437919

Access funding benchmarks and valuations. Sign up today!

View details of Optain's funding rounds and investors

Optain's employee count trend

Optain has 47 employees as of Sep 26. Here is Optain's employee count trend over the years:

Uncover Optain's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Optain include Remidio, Intelligent Retinal Imaging Systems and PeriVision. Here is the list of Top 10 competitors of Optain, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Remidio 2009, Bengaluru (India), Series B	Developer of AI-powered portable digital solutions for ophthalmic screening and diagnosis	$25M	Montane Ventures, KITVEN & 32 others	65/100
2nd	Intelligent Retinal Imaging Systems 2011, Pensacola (United States), Acquired	Telemedicine system for the early detection of diabetic eye disease	$13.3M	Ballast Point Ventures, Allumia Ventures & 1 others	60/100
3rd	PeriVision 2019, Epalinges (Switzerland), Seed	SaaS and AI based vision care clinical workflow for professionals and patients	$4.69M	Swiss ICT Investor Club, DART Ventures & 11 others	58/100
4th	Heru 2018, Miami (United States), Series A	AI-based medical vision diagnostic device and platform	$36.7M	Open Opportunity Fund, Krillion Ventures & 3 others	55/100
5th	Optain 2023, New York City (United States), Series A	AI-powered retinal imaging technology for non-invasive evaluation of patients	$38M	Insight Partners, UPMC & 8 others	54/100
6th	AIOptics 2020, New York (United States), Series B	Provider of AI-based digital platform and device to prevent blindness	$14.7M	Octane, HHS	49/100
7th	Topconhealthcare 2018, Oakland (United States), Unfunded	-	-	-	47/100
8th	Oivi 2017, Oslo (Norway), Seed	Online platform for tracking eye diseases through teleconsultation	$500K	Arali Ventures, EIC Fund & 5 others	46/100
9th	Artelus 2015, Bengaluru (India), Seed	AI based platform for medical diagnosis	$521K	L V Prasad Eye Institute	44/100
10th	Optina 2011, Montreal (Canada), Series A	Provider of AI-driven clinical decision support for retinal disease diagnosis	$23.7M	Zoic, DigitalDx Ventures & 10 others	37/100